• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对肾癌的性别特异性代谢组学方法。

Gender-Specific Metabolomics Approach to Kidney Cancer.

作者信息

Deja Stanisław, Litarski Adam, Mielko Karolina Anna, Pudełko-Malik Natalia, Wojtowicz Wojciech, Zabek Adam, Szydełko Tomasz, Młynarz Piotr

机构信息

Center for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

出版信息

Metabolites. 2021 Nov 10;11(11):767. doi: 10.3390/metabo11110767.

DOI:10.3390/metabo11110767
PMID:34822425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8624667/
Abstract

Renal cell carcinoma (RCC) is the most common form of kidney malignancy. RCC is more common among men with a 2/1 male/female incidence ratio worldwide. Given the underlying epidemiological differences in the RCC incidence between males and females, we explored the gender specific H NMR serum metabolic profiles of RCC patients and their matched controls. A number of differential metabolites were shared by male and female RCC patients. These RCC specific changes included lower lactate, threonine, histidine, and choline levels together with increased levels of pyruvate, -acetylated glycoproteins, beta-hydroxybutyrate, acetoacetate, and lysine. Additionally, serum lactate/pyruvate ratio was a strong predictor of RCC status regardless of gender. Although only moderate changes in metabolic profiles were observed between control males and females there were substantial gender related differences among RCC patients. Gender specific metabolic features associated with RCC status were identified suggesting that different metabolic panels could be leveraged for a more precise diagnostic.

摘要

肾细胞癌(RCC)是最常见的肾脏恶性肿瘤形式。RCC在男性中更为常见,全球范围内男性与女性的发病率之比为2:1。鉴于男性和女性RCC发病率存在潜在的流行病学差异,我们探索了RCC患者及其匹配对照的性别特异性1H NMR血清代谢谱。男性和女性RCC患者有一些共同的差异代谢物。这些RCC特异性变化包括乳酸、苏氨酸、组氨酸和胆碱水平降低,同时丙酮酸、N-乙酰化糖蛋白、β-羟基丁酸、乙酰乙酸和赖氨酸水平升高。此外,无论性别如何,血清乳酸/丙酮酸比值都是RCC状态的有力预测指标。尽管在对照男性和女性之间仅观察到代谢谱的中度变化,但RCC患者之间存在显著的性别相关差异。确定了与RCC状态相关的性别特异性代谢特征,表明可以利用不同的代谢组进行更精确的诊断。

相似文献

1
Gender-Specific Metabolomics Approach to Kidney Cancer.针对肾癌的性别特异性代谢组学方法。
Metabolites. 2021 Nov 10;11(11):767. doi: 10.3390/metabo11110767.
2
(1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool.(1)基于~1H NMR 的代谢组学分析在肾细胞癌中的应用:一种可能的诊断工具。
J Proteome Res. 2010 Aug 6;9(8):4038-44. doi: 10.1021/pr100226m.
3
Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps.基于核磁共振的血清代谢组学和自组织映射技术对肾细胞癌的预测与诊断
Oncotarget. 2016 Sep 13;7(37):59189-59198. doi: 10.18632/oncotarget.10830.
4
UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.基于 UPLC-MS 的尿液非靶向代谢组学分析用于膀胱癌与肾细胞癌的鉴别诊断。
BMC Cancer. 2019 Dec 5;19(1):1195. doi: 10.1186/s12885-019-6354-1.
5
A pilot investigation of a urinary metabolic biomarker discovery in renal cell carcinoma.在肾细胞癌中进行尿液代谢生物标志物发现的初步研究。
Int Urol Nephrol. 2020 Mar;52(3):437-446. doi: 10.1007/s11255-019-02332-w. Epub 2019 Nov 16.
6
Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases.应用离体(1)H NMR 代谢组学对肾细胞癌转移的特征化和可能检测。
J Cancer Res Clin Oncol. 2012 May;138(5):753-61. doi: 10.1007/s00432-011-1134-6. Epub 2012 Jan 19.
7
GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.基于气相色谱-质谱联用代谢组学的方法用于鉴定肾细胞癌患者尿液中潜在的挥发性有机化合物生物标志物组合。
J Cell Mol Med. 2017 Sep;21(9):2092-2105. doi: 10.1111/jcmm.13132. Epub 2017 Apr 4.
8
Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.磁共振代谢组学揭示了肾细胞癌的排泄代谢特征。
Sci Rep. 2016 Nov 18;6:37275. doi: 10.1038/srep37275.
9
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.肾细胞癌亚型中的代谢和脂质组学重编程反映了肿瘤起源区域。
Eur Urol Focus. 2019 Jul;5(4):608-618. doi: 10.1016/j.euf.2018.01.016. Epub 2018 Feb 13.
10
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics.肾细胞癌:一项基于核磁共振代谢组学与转录组学相结合的研究
Diseases. 2016 Jan 22;4(1):7. doi: 10.3390/diseases4010007.

引用本文的文献

1
Untargeted metabolomic profiling of serum and urine in kidney cancer: a non-invasive approach for biomarker discovery.肾癌血清和尿液的非靶向代谢组学分析:一种发现生物标志物的非侵入性方法。
Metabolomics. 2025 Jul 1;21(4):97. doi: 10.1007/s11306-025-02294-4.
2
Influence of Dietary Polyunsaturated Fatty Acid Intake on Potential Lipid Metabolite Diagnostic Markers in Renal Cell Carcinoma: A Case-Control Study.饮食多不饱和脂肪酸摄入对肾细胞癌潜在脂质代谢物诊断标志物的影响:病例对照研究。
Nutrients. 2024 Apr 24;16(9):1265. doi: 10.3390/nu16091265.
3
Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma.

本文引用的文献

1
Serum and urine analysis with gold nanoparticle-assisted laser desorption/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery.利用金纳米颗粒辅助激光解吸/电离质谱法进行血清和尿液分析以发现肾细胞癌代谢生物标志物
Adv Med Sci. 2021 Sep;66(2):326-335. doi: 10.1016/j.advms.2021.07.003. Epub 2021 Jul 14.
2
Ins and Outs of the TCA Cycle: The Central Role of Anaplerosis.三羧酸循环的来龙去脉:回补反应的核心作用
Annu Rev Nutr. 2021 Oct 11;41:19-47. doi: 10.1146/annurev-nutr-120420-025558. Epub 2021 Jul 16.
3
The Promise of Tubule Biomarkers in Kidney Disease: A Review.
肾细胞癌不同阶段的血浆代谢组学分析
Cancers (Basel). 2022 Dec 26;15(1):140. doi: 10.3390/cancers15010140.
管型生物标志物在肾脏疾病中的应用前景:综述。
Am J Kidney Dis. 2021 Nov;78(5):719-727. doi: 10.1053/j.ajkd.2021.03.026. Epub 2021 May 27.
4
In Vivo Estimation of Ketogenesis Using Metabolic Flux Analysis-Technical Aspects and Model Interpretation.使用代谢通量分析对生酮作用进行体内评估——技术要点与模型解读
Metabolites. 2021 Apr 28;11(5):279. doi: 10.3390/metabo11050279.
5
Sex differences in systemic metabolites at four life stages: cohort study with repeated metabolomics.四个生命阶段的系统代谢物中的性别差异:队列研究与重复代谢组学。
BMC Med. 2021 Feb 24;19(1):58. doi: 10.1186/s12916-021-01929-2.
6
Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based metabolome profiling of urine samples from kidney cancer patients.基于磁共振和表面辅助激光解吸/电离质谱的肾癌患者尿液代谢组学分析。
J Pharm Biomed Anal. 2021 Jan 30;193:113752. doi: 10.1016/j.jpba.2020.113752. Epub 2020 Nov 6.
7
The Redox Communication Network as a Regulator of Metabolism.作为代谢调节因子的氧化还原通讯网络
Front Physiol. 2020 Oct 15;11:567796. doi: 10.3389/fphys.2020.567796. eCollection 2020.
8
Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer.基于磁共振和表面辅助激光解吸/电离质谱的肾癌血清代谢组学研究。
Anal Bioanal Chem. 2020 Sep;412(23):5827-5841. doi: 10.1007/s00216-020-02807-1. Epub 2020 Jul 13.
9
Trends and projections of kidney cancer incidence at the global and national levels, 1990-2030: a Bayesian age-period-cohort modeling study.1990 - 2030年全球及国家层面肾癌发病率的趋势与预测:一项贝叶斯年龄-时期-队列建模研究
Biomark Res. 2020 May 13;8:16. doi: 10.1186/s40364-020-00195-3. eCollection 2020.
10
Gender-Related Approach to Kidney Cancer Management: Moving Forward.性别相关的肾癌管理方法:展望未来。
Int J Mol Sci. 2020 May 10;21(9):3378. doi: 10.3390/ijms21093378.